Shares of bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $116.05 and traded as low as $110.57. bioMérieux shares last traded at $110.57, with a volume of 9 shares trading hands.
Wall Street Analyst Weigh In
Separately, UBS Group upgraded shares of bioMérieux to a "strong-buy" rating in a research note on Thursday, August 22nd.
Read Our Latest Stock Report on bioMérieux
bioMérieux Stock Down 3.8 %
The stock's fifty day simple moving average is $116.05 and its 200-day simple moving average is $107.54.
bioMérieux Company Profile
(
Get Free Report)
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Featured Articles
Before you consider bioMérieux, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and bioMérieux wasn't on the list.
While bioMérieux currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
